PAHC(PAHC)
PAHC
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $1.55B | $1.60B | $1.65B | $1.70B |
| Low | $1.54B | $1.60B | $1.64B | $1.68B |
| High | $1.55B | $1.60B | $1.65B | $1.70B |
| EBITDA Avg | $169M | $175M | $180M | $185M |
| Low | $168M | $175M | $179M | $184M |
| High | $170M | $175M | $181M | $186M |
| EBIT Avg | $114M | $118M | $121M | $125M |
| Low | $113M | $118M | $120M | $124M |
| High | $114M | $118M | $122M | $125M |
| Net Income Avg | $136M | $149M | $177M | $197M |
| Low | $130M | $148M | $176M | $195M |
| High | $142M | $151M | $178M | $197M |
| EPS Avg | $3.34 | $3.68 | $4.36 | $4.83 |
| Low | $3.19 | $3.65 | $4.32 | $4.78 |
| High | $3.49 | $3.70 | $4.38 | $4.85 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $376M | $418M | $430M | $442M |
| Low | $376M | $418M | $430M | $442M |
| High | $376M | $418M | $430M | $442M |
| EBITDA Avg | $41M | $46M | $47M | $48M |
| Low | $41M | $46M | $47M | $48M |
| High | $41M | $46M | $47M | $48M |
| EBIT Avg | $28M | $31M | $32M | $33M |
| Low | $28M | $31M | $32M | $33M |
| High | $28M | $31M | $32M | $33M |
| Net Income Avg | $32M | $37M | $33M | $30M |
| Low | $32M | $37M | $33M | $30M |
| High | $32M | $37M | $33M | $30M |
| EPS Avg | $0.79 | $0.91 | $0.80 | $0.74 |
| Low | $0.79 | $0.91 | $0.80 | $0.74 |
| High | $0.79 | $0.91 | $0.80 | $0.74 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |